Radioimmunodetection of colorectal carcinoma

Hepato-Gastroenterology

Volumn 50, Issue 52, 2003, Pages 1029-1031

  Artiko, V ^a   Obradovic, Vladimir ^a,e   Davidovic, B ^a   Petrovic, N ^a   Petrovic, M ^b   Krivokapic, Z ^b   Kecmanovic, D ^b   Pesko, P ^b   Djukic, V ^c   Milosavljevic, T ^b   Adanja, G ^a   Vlajkovic, M ^d  

^a Institute for Nuclear Medicine   (Serbia)

^b Institute for Cardiovascular Diseases   (Serbia)

^c CCS   (Serbia)

^d Center for Nuclear Medicine   (Serbia)

^e CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Colorectal carcinoma; Immunoscintigraphy

Indexed keywords

MONOCLONAL ANTIBODY B.72.3; MONOCLONAL ANTIBODY B.72.3 IN 111;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; METASTASIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOMOSCINTIGRAPHY; TUMOR VOLUME;

EID: 0037662947     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Colcher D, Hand HP, Nuti M, Schlom J: A spectrum of monoclonal antibodies reactive with mammary tumour cells. Proc Natl Acad Sci USA 1981; 78(5):3199-3203.
2. Johnson VG, Schlom J, Paterson AJ, et al: Analysis of a human associated B72.3. Cancer Res 1986; 46:850-857.
3. Thor A, Gorsten F, Ohuchi N, Szpak C, Johnston WW, Schlom J: Tumor associated glycoprotein (TAG 72) in ovarian carcinomas defined by monoclonal antibody B 72.3.J Natl Cancer Inst 1986; 76:995-1004.
4. Thor A, Gorsten F, Ohuchi N, Szpak C, Jonhnston WW, Schlom J: Distribution of oncofetal antigen tumor associated glycoprotein 72 defined by monoclonal antibody B 72.3. Cancer Res 1986; 46:3118-3124.
5. Rodwell JD, Alvarez VL, Lee C, et al: Site specific covalent modification of monoclonal antibodies, in vitro and in vivo evaluations. proc Natl Acad Sci USA 1986; 83:2632-2636.
6. Thor AD, Edgerton SM: Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications. Sem Nucl Med 1989; 19:295-308.
7. Thor A, Viglione MJ, Murar J, et al: Monoclonal antibody B 72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int J Gynecol Pathol 1987; 6:235-247.
8. Abdel-Nabi, HH, Chan HW, Doerr RJ: Indium-labeled anti-colorectal carcinoma monoclonal antibody accumulation in non-tumored tissue in patients with colorectal carcinoma. J Nucl Med 1990; 31:1975-1979.
9. Doerr RJ, Abdel-Nabi, H, Krag D, et al: Radiolabeled antibody imaging in the management of colorectal cancer: results of a multicenter clinical study. Ann Surg 1991; 214:118-124.
10. Abdel-Nabi HH, Doerr RJ, Chan HW, et al: Safety and role of repeated administrations of Indium-111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE 025 in the postoperative follow-up of colorectal carcinoma patients. J Nucl Med 1992; 33:14-22.
11. Patt YZ, Podoloff DA, Curley S, et al: Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen: experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials. Cancer 1993; 71(Suppl 12):4293-4297.
12. Volpe CM, Abdel-Nabi HH, Kulaylat MN, Doerr RJ: Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer. Ann Surg Oncol 1998; 5:489-494.
13. Tempero M: Pitfalls in antibody imaging in colorectal cancer. Cancer 1993; 71(Suppl 12):4248-4251.
14. Winzelberg GG, Grossman SJ, Rizk S, et al: Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer: correlation with computed tomography, surgery, histopathology, immunohistology and human immune response. Cancer 1992; 69:1656-1663.
15. 111 In monoclonal antibodies. Nucl Med Commun 1995; 16:631-639.
16. Neal CE, Johnson DL, Cornell VL, Markwell S: Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis. Clin Nucl Med 1996; 1:638-642.
17. 111 In-CYT-103 scanning in recurrent colorectal cancer - does it affect standard management? Dis Colon Rectum 1996; 39:514-519.
18. Edlin JP, Kahn D: Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient ith nondiagnostic MRI and CT. Clin Nucl Med 1994; 19:1004-1007.
19. Goldenberg DM: Perspectives on oncologic imaging with radiolabeled antibodies. Cancer 1997; 15:431-435.
20. Pinkas L, Robins PD, Forstrom LA, Mahoney DW, Mullan BP: Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature. Nucl Med Commun 1999; 20:689-696.
21. Ryan JW: Immunoscintigraphy in primary colorectal cancer: Cancer 1993; 71(Suppl 12):4217-4224.
22. 99m TC-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000; 41:1657-1663.
23. 111 In-labelled anti TAG72 monoclonal antibody. Nucl Med Commun 1999; 20:13-30.